To our knowledge, this comparative cross-sectional study is the first to compare the expression levels of CD44, CD133, and VDR between patients with different types of epithelial ovarian tumors, including BOT, APT, and five types of OC. The gene discussed is PROM1; the disease is ovarian epithelial tumor.